OVERVIEW

The 6th World Psoriasis & Psoriatic Arthritis Conference (WPPAC) 2021 is organized by International Federation of Psoriasis Associations (IFPA) and will be held from Jun 30 - Jul 03, 2021.

Theme: The conference theme is CONNECTED, INFORMED, and UNITED to improve multidisciplinary care for people with psoriasis and psoriatic arthritis.

Description:
The World Psoriasis & Psoriatic Arthritis Conference is an established scientific conference organized by IFPA. It presents the latest developments in psoriasis and psoriatic arthritis research. Because medical professionals from both the dermatology and rheumatology field attend, the conference provides a unique cross-specialty forum. Delegates can explore the psoriasis disease from different perspectives by networking with patients and industry representatives in attendance. Since 2006, we have organized the World Conference every third year. The latest conference drew over 1,100 delegates from across the world. Our aim with the World Psoriasis & Psoriatic Arthritis Conference is to:
• Increase global recognition of the psoriasis disease and its severity;
• Unite psoriasis stakeholders, to strengthen international collaboration;
• Share the latest scientific and clinical developments on psoriasis;
• Encourage new research projects;
• Highlight the patient perspective, so that the conference will ultimately improve living conditions for the international psoriasis community.

Topics:
The conference program will feature topics of interest for everyone active within the fields of psoriasis and psoriatic arthritis – clinicians as well as researchers – covering areas such as:
• Psoriasis/psoriatic arthritis and infectious disease – what are we learning from the Covid-19 pandemic?
• Unmet needs
? Access to therapy
? Physician recognition of patient needs
? Policy and decision-makers – what is needed to improve treatment and care
• Long-term safety and outcomes data
• New pathways and ”drivers” of immunity
• Digital medicine
? Focus on: treatment, self-management, psychosocial issues and Quality of Life
• Comorbidities – awareness and management

Additional details will be posted as soon as information is available.